Response to Pendleton et al. regarding reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States.
Hariri, Susan; Markowitz, Lauri E; Unger, Elizabeth R.
; 34(2): 201, 2016 Jan 04.
Artigo em Inglês | MEDLINE | ID: mdl-26655631
Monitoring the impact of a national HPV vaccination program in Japan (MINT Study): rationale, design and methods.
A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries.
Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States - 2008-2012.
No evidence in US of HPV16/18 cancer precursor reduction.
Declines in Human Papillomavirus (HPV)-Associated High-Grade Cervical Lesions After Introduction of HPV Vaccines in Connecticut, United States, 2008-2015.
Dietary methionine restriction inhibits prostatic intraepithelial neoplasia in TRAMP mice.
Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia.
Conservative Treatment Seems the Best Choice in Adenocarcinoma In Situ of the Cervix Uteri.
HPV type attribution in high-grade cervical lesions: assessing the potential benefits of vaccines in a population-based evaluation in the United States.
Viral load of human papillomavirus types 16/18/31/33/45 as a predictor of cervical intraepithelial neoplasia and cancer by age.